12:00 AM
 | 
May 25, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Procrit epoetin alfa hematology data

A retrospective study of medical claims data from the PharMetrics Patient-Centric database of about 85 health plans from January 2006 to January 2008 showed that in 10,928 cancer chemotherapy patients, the cumulative drug cost was 29% less for patients receiving Procrit epoetin...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >